Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07122427

Aging of the Vascular Wall

Demographic aging is predicted to be one of the most significant social changes of the 21st century. Aging is a slow, multifactorial process that progressively impacts the integrity of cells, tissues, and organs. This decline in function increases the risk of numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases (CVD). CVD, the leading global cause of death, becomes more prevalent with age. Aging contributes to endothelial dysfunction, vessel stiffness, thickening, and impaired platelet function. These changes disrupt hemostatic processes and increase the risk of cardiovascular complications. Despite preventive strategies CVD remain a major public health challenge. Cellular aging, or senescence, affects all cell types, particularly endothelial cells and platelets. However, little research has compared the aging rates of different blood vessel types, such as arteries and veins. Given their distinct compositions and developmental origins, it is likely that their aging processes differ at molecular, cellular, and physiological levels.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Saint-Etienne

Saint-Etienne, France, 42055

Location status: Recruiting

Location contact

Anne-Claire DUCHEZ, PhD

CONTACT

[email protected]

(0)477421423 ext. +33

Anne-Claire DUCHEZ, PhD

SUB_INVESTIGATOR

Salvatore CAMPISI, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major patients requiring coronary artery bypass grafting (CABG).

Exclusion criteria

  • Hypertension, diabetes, systemic inflammatory disease.

Treatment and study plan

Graft collection

Procedure

Sampling of superior venous and arterial grafts (internal mammary artery, great saphenous vein) after coronary artery bypass surgery.

Primary outcomes

  1. Biomarkers of ageing

    Time frame: Day 1

    Detection of innovative biomarkers of ageing by microscope analysis.

Study contacts

Contact information is provided by the study sponsor or research team.

Anne-Claire DUCHEZ, PhD

CONTACT

[email protected]

(0)477421423 ext. +33

Salvatore CAMPISI, MD

CONTACT

[email protected]

(0)477829058 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Acronym: VITAL

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 14, 2025
Registry last updated
Aug 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.